Brief: Theratechnologies Announces Data From Oral Presentation At Aasld Showing How Tesamorelin Can Reduce Fibrosis And Nash
Nov 16 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES ANNOUNCES DATA FROM ORAL PRESENTATION AT
AASLD
SHOWING HOW TESAMORELIN CAN REDUCE FIBROSIS AND NASH
Source text for Eikon: ID:nGNX1NQVVg
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process